What coagulation workup should be performed after a pulmonary embolism (PE) and deep vein thrombosis (DVT)?

Coagulation Workup After PE and DVT

Routine thrombophilia testing is NOT indicated after a first episode of PE or DVT 1, 2. The coagulation workup should be highly selective and driven by specific clinical scenarios rather than reflexive laboratory screening.

When to Perform Thrombophilia Testing

Testing for heritable thrombophilic defects does not usefully predict recurrence risk after a first VTE episode 1. However, consider selective testing only in these specific situations:

• Strong family history of unprovoked recurrent thrombosis in multiple first-degree relatives
• Recurrent unprovoked VTE (two or more episodes)
• Unusual thrombosis sites (e.g., cerebral, mesenteric, portal veins)
• Young patients (<40 years) with unprovoked VTE and no other risk factors

Important caveat: Even with a strong family history, testing is a poor predictor of identifying heritable defects 1, so this should not be routine.

Antiphospholipid Syndrome Testing

Test for antiphospholipid antibodies specifically when:

• VTE is unprovoked and patient requires extended anticoagulation decisions
• History suggests autoimmune disease
• Recurrent pregnancy loss or other clinical features of antiphospholipid syndrome

Risk Stratification Tools (More Useful Than Thrombophilia Testing)

Instead of reflexive coagulation panels, focus on these evidence-based predictors of recurrence:

D-dimer Testing (Most Useful)

• Measure 3-4 weeks after stopping anticoagulation 1
• Low D-dimer: 4% annual recurrence risk
• High D-dimer: 9% annual recurrence risk 1
• This provides more clinically useful information than thrombophilia testing

Clinical Risk Factors to Document

• Provoked vs. unprovoked: Most critical distinction 1
  • Surgery-provoked: <1% annual recurrence (stop at 3 months)
  • Unprovoked: >5% annual recurrence (consider extended therapy) 1
• Male gender: 1.8-fold higher recurrence risk 1
• PE vs. DVT presentation: PE patients have 3-4 times higher risk of recurrent PE and 2-4 times higher risk of fatal PE 1
• Post-thrombotic syndrome: 2.6-fold increased recurrence risk 1

Practical Algorithm

For ALL patients after PE/DVT:

1. Document whether VTE was provoked or unprovoked
2. Assess bleeding risk during initial 3-6 months of treatment (INR control, bleeding episodes)
3. Do NOT order routine thrombophilia panels

At 3 months (when considering extended anticoagulation):

1. If provoked by surgery/major trauma: STOP anticoagulation 1
2. If unprovoked PE or proximal DVT:
   • Check D-dimer 3-4 weeks after stopping anticoagulation 1
   • Consider extended anticoagulation based on bleeding risk and patient preference 3, 1
3. If unprovoked distal DVT only: Stop at 3 months 1

Reserve thrombophilia testing for:

• Age <40 with unprovoked VTE AND strong family history
• Recurrent unprovoked VTE (≥2 episodes)
• Unusual thrombosis sites

Common Pitfalls to Avoid

• Don't test during acute anticoagulation: Many tests (protein C, protein S, antithrombin) are unreliable on anticoagulants
• Don't let negative thrombophilia testing reassure you: Absence of detectable thrombophilia does NOT reduce recurrence risk enough to stop anticoagulation in unprovoked VTE 1
• Don't test for residual vein occlusion: Ultrasound findings of residual thrombus do NOT predict recurrence usefully 1

The most recent ASH 2020 guidelines 3 emphasize that treatment duration decisions should be based on whether VTE was provoked or unprovoked, bleeding risk assessment, and patient values—not on thrombophilia testing results.